SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

Share Price is delayed by 15 minutes
Get Live Data
7.50    0.00 (0.00%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £70.80m
DPP Live PriceLast checked at - London Stock Exchange

Intraday Dp Poland Share Chart

Holding(s) in Company

1 Oct 2020 10:39

RNS Number : 8026A
DP Poland PLC
01 October 2020
Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DP POLAND PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Transfers out by discretionary clients

X

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

28 SEPTEMBER 2020

6. Date on which issuer notified (DD/MM/YYYY):

30 SEPTEMBER 2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

11.9479

11.9479

253,969,093

Position of previous notification (if

applicable)

12.6470

12.6470

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B3Q74M51

30,343,986

11.9479

SUBTOTAL 8. A

30,343,986

11.9479

Β 

Β 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Β 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Β 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Β 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Β 

Canaccord Genuity Group Inc.

11.9479

11.9479

Β 

Canaccord Genuity Wealth Group Holdings Limited

11.9479

11.9479

Β 

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

11.9479

11.9479

Β 

Canaccord Genuity Wealth Group Limited

11.9479

11.9479

Β 

Canaccord Genuity Wealth Limited

0.0215

0.0215

Β 

Hargreave Hale Ltd

11.9264

11.9264

Β 

Β 

10. In case of proxy voting, please identify:

Β 

Name of the proxy holder

Β 

The number and % of voting rights held

Β 

The date until which the voting rights will be held

Β 

Β 

11. Additional informationxvi

Β 

Β 

Β 

Β 

Place of completion

BLACKPOOL, ENGLAND

Date of completion

30 SEPTEMBER 2020

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
HOLFIFVAIDLLIII
Date   Source Headline
29th May 202612:00 pmRNS2025 Annual Report and Notice of 2026 AGM
28th May 20267:00 amRNSFinal Results 2025 and Investor Presentation
14th Apr 20267:00 amRNSQ1 2026 Trading Update
12th Mar 20267:00 amRNS-RYellowstone Advisory Private Investor Evening
9th Mar 20267:00 amRNSAppointment of Non-Executive Director
5th Feb 20267:00 amRNSBoard Changes
14th Jan 20267:00 amRNSFull Year Trading Update
27th Nov 20257:00 amRNSNew Financing Arrangements
20th Oct 20257:00 amRNSRenewal of Master Franchise Agreement
14th Oct 20257:00 amRNSQ3 2025 Trading Update
15th Sep 20257:00 amRNSInterim Results and Trading Update
12th Sep 20257:00 amRNSNotice of Results & Investor Presentation
24th Jul 20254:26 pmRNSResult of AGM
10th Jul 20257:00 amRNSTrading Update
30th Jun 202510:04 amRNS2024 Annual Report and Notice of AGM
27th Jun 20257:00 amRNSFinal Results 2024 and Investor Presentation
23rd May 20254:01 pmRNSTiming of Final Results
16th Apr 20257:00 amRNSTrading Update
10th Apr 202512:15 pmRNSHolding(s) in Company
1st Apr 20257:00 amRNSChange of Registered Office
27th Mar 20257:00 amRNSStrategic Acquisition
28th Feb 202512:15 pmRNSExercise of Options & TVR
16th Jan 20257:00 amRNSFull Year unaudited Trading Update for 2024
4th Nov 20247:00 amRNSTrading Update
4th Oct 202410:00 amRNSDirector/PDMR Dealing
17th Sep 20247:00 amRNSInterim Results & Trading Update
30th Aug 20247:00 amRNSNotice of Results and Investor Presentation
11th Jul 20247:00 amRNSTrading Update
27th Jun 20241:07 pmRNSResult of AGM
3rd Jun 20248:42 amRNSPosting of Annual Report & Notice of AGM
31st May 20247:00 amRNSFinal Results
20th May 20248:56 amRNSGrant of Options (Replacement)
29th Apr 202412:30 pmRNSGrant of Options
29th Apr 20247:00 amRNSTrading Update
25th Apr 20244:50 pmRNSExercise of Options & TVR
19th Apr 20241:21 pmRNSHolding(s) in Company
19th Apr 20249:57 amRNSDirector/PDMR Dealing
18th Apr 20241:40 pmRNSResult of General Meeting
16th Apr 20247:00 amRNSResult of Retail Offer
3rd Apr 20247:00 amRNSPublication of Circular
28th Mar 20244:01 pmRNSLaunch of Retail Offer
28th Mar 20244:00 pmRNSResult of Placing
28th Mar 202411:05 amRNSClose of Bookbuild
27th Mar 20244:45 pmRNSProposed Fundraise
16th Jan 20247:00 amRNSTrading Update
15th Nov 20237:00 amRNSBoard Changes
14th Nov 20237:00 amRNSTrading Update
10th Oct 20237:00 amRNSBoard Changes
26th Sep 20237:00 amRNSInterim Results & Trading Update
22nd Sep 20237:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.